Answers are grounded in this paper and cite their sources.
A Bayesian model predicts outcomes in small areas, suggesting improved accuracy in non-normal distributions.
We present a new semiparametric extension of the Fay-Herriot model, termed the agnostic Fay-Herriot model (AGFH), in which the sampling-level model is expressed in terms of an unknown general function g(·). Thus, the AGFH model can express any distribution in the sampling model since the choice of g(·) is extremely broad. We propose a Bayesian modelling scheme for AGFH where the unknown function g(·) is assigned a Gaussian Process prior. Using a Metropolis within Gibbs sampling Markov Chain Monte Carlo scheme, we study the performance of the AGFH model, along with that of a hierarchical Bayesian extension of the Fay-Herriot model. Our analysis shows that the AGFH is an excellent modelling alternative when the sampling distribution is non-Normal, especially in the case where the sampling distribution is bounded. It is also the best choice when the sampling variance is high. However, the hierarchical Bayesian framework and the traditional empirical Bayesian framework can be good modelling alternatives when the signal-to-noise ratio is high, and there are computational constraints.
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: